Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Goldkind

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Military Medicine|May 19, 2012
A 5-year retrospective review of experience with Clostridium difficile-associated diarrheaSteven Armbruster, Lawrence Goldkind
Pharmacoepidemiology and Drug Safety|February 4, 2006
A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experienceLawrence Goldkind, Loren Laine
Arthritis Research & Therapy|March 18, 2006
Patients, their doctors, nonsteroidal anti-inflammatory drugs and the perception of riskLawrence Goldkind, Lee S Simon
Arthritis Research & Therapy|September 20, 2005
Balancing the gastrointestinal benefits and risks of nonselective NSAIDsDavid A Peura, Lawrence Goldkind
Southern Medical Journal|March 13, 2009
An unusual case of colonic ischemiaFouad J Moawad, Lawrence Goldkind
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2005
Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patientsAlaa Rostom, Lawrence Goldkind, Loren Laine
Gastroenterology|August 7, 2022
ReplyLawrence Goldkind, Andrew E Mulberg, Janice Soreth
Drugs & Aging|May 11, 2004
Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozinAllen Brinker, Lawrence Goldkind, Renan Bonnel, et al.
Gastroenterology|July 10, 2022
Regulatory and Clinical Expert Perspective of the 2022 FDA Draft Guidance "Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet"Lawrence Goldkind, Janice M Soreth, Andrew E Mulberg
BMJ Case Reports|December 4, 2019
Treatment-resistant severe capecitabine-induced diarrhoea resolved with oral budesonideJohn Shumar, Zachary Junga, Jeptha T Johnson, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Military Medicine|May 19, 2012
A 5-year retrospective review of experience with Clostridium difficile-associated diarrheaSteven Armbruster, Lawrence Goldkind
Pharmacoepidemiology and Drug Safety|February 4, 2006
A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experienceLawrence Goldkind, Loren Laine
Arthritis Research & Therapy|March 18, 2006
Patients, their doctors, nonsteroidal anti-inflammatory drugs and the perception of riskLawrence Goldkind, Lee S Simon
Arthritis Research & Therapy|September 20, 2005
Balancing the gastrointestinal benefits and risks of nonselective NSAIDsDavid A Peura, Lawrence Goldkind
Southern Medical Journal|March 13, 2009
An unusual case of colonic ischemiaFouad J Moawad, Lawrence Goldkind
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 10, 2005
Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patientsAlaa Rostom, Lawrence Goldkind, Loren Laine
Gastroenterology|August 7, 2022
ReplyLawrence Goldkind, Andrew E Mulberg, Janice Soreth
Drugs & Aging|May 11, 2004
Spontaneous reports of hypertension leading to hospitalisation in association with rofecoxib, celecoxib, nabumetone and oxaprozinAllen Brinker, Lawrence Goldkind, Renan Bonnel, et al.
Gastroenterology|July 10, 2022
Regulatory and Clinical Expert Perspective of the 2022 FDA Draft Guidance "Celiac Disease: Developing Drugs for Adjunctive Treatment to a Gluten-Free Diet"Lawrence Goldkind, Janice M Soreth, Andrew E Mulberg
BMJ Case Reports|December 4, 2019
Treatment-resistant severe capecitabine-induced diarrhoea resolved with oral budesonideJohn Shumar, Zachary Junga, Jeptha T Johnson, et al.
Pageof 2